Poster Abstract Session:
253. Transplant Infections - Epidemiology
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Predictive Models of Fever and Adverse Outcomes in Hospitalized Patients with Neutropenia
Elizabeth Gulleen, MD; Mawulolo Ameko, MS; John Ainsworth, MS; Prabhat Rayapati, MS; Laura Barnes, PhD; Christopher Moore, MD
Infectious Complications of Bronchial Stenosis in Lung Transplant Recipients
Lindsay Jablonski, MD; Sean Moss, MD; Rebecca Fallis, MD; Peter Axelrod, MD; Heather Clauss, M.D.
Infectious Complications of CD19-Targeted Chimeric Antigen Receptor-Modified T Cell Immunotherapy
Joshua Hill, MD; Daniel Li, PhD; Kevin Hay, MD; Margaret L. Green, MD, MPH; Stanley Riddell, MD, PhD; David Maloney, MD, PhD; Michael Boeckh, MD, PhD, FIDSA; Cameron Turtle, MD, PhD
  • IDWkPoster_2017.pdf (2.3 MB)
  • Opportunistic Infections (OIs) in Patients with Hematologic Malignancies (HM) Treated with Bruton’s tyrosine kinase (BTK) and Phosphoinositide 3 kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study.
    Nicolas Issa, MD; Esther Arbona-Haddad, MD; Alexandra Nevett-Fernandez, MD; Daniel Prestes, MD; Alexis Liakos, PA-C; Ann Woolley, MD; Sarah Hammond, MD; Jennifer Brown, MD; Lindsey Baden, MD; Francisco Marty, MD
  • Ibrutinib poster Final.pdf (297.8 kB)
  • Prediction of Febrile Neutropenia after Chemotherapy Based on Pre-treatment Risk Factors among Cancer Patients
    Theis Aagaard, MD; Ashley Roen, MA; Gedske Daugaard, MD, DMSc, Professor; Peter Brown, MD, PhD; Henrik Sengeløv, MD; Amanda Mocroft, MSc, Professor; Jens Lundgren, MD, DMSc, Professor; Marie Helleberg, MD, PhD, DMSc
  • Theis Aagaard - IDweek 2017.pdf (419.1 kB)
  • Infections in Patients Receiving Ibrutinib for Treatment of Lymphoma - A Single Center Experience
    Tilly A. Varughese, MD; Gil Redelman-Sidi, MD; Nina Cohen, PharmD; Susan K. Seo, MD; Tobias M. Hohl, MD, PhD, FIDSA
    A Contemporary Analysis of Neutropenic Fever in Leukemia Patients Presenting to the Emergency Center – Importance of Pneumonia
    Deeksha Jandhyala, M.D.; Victor E. Mulanovich, MD; Samuel L. Aitken, PharmD; Frank P. Tverdek, PharmD; Roy Chemaly, MD, MPH; Kayleigh R. Marx, PharmD; Kenneth V. I. Rolston, MD; Samuel A. Shelburne, MD, PhD
    Lymphopenia after Radiotherapy and Risk of Infection
    Cynthia Terrones, MD; Lena Specht, MD, DMSc; Maja V. Maraldo, MD, PhD; Jens Lundgren, MD, DMSc, Professor; Marie Helleberg, MD, PhD, DMSc
  • Poster IDWeek 2017 v5_CYT.pdf (406.8 kB)
  • Trypanozoma cruzi infection in patients undergoing solid organ transplantation
    Noelia Mañez, MD infectious diseases fellow; Manuel Alderete Jr., MD; Jose Benso, MD; Alejandra Valledor, Infectious Diseases Specialist; Astrid Smud, MD Infectious Diseases specialist; Alejandro Schijman, Ph.D; Susana Besuschio, Chem; Laura Barcan, MD infectious diseases specialist
    Infection Risk Associated with Daratumumab
    Joyce J Johnsrud, MD; Sandra Susanibar, MD; Jorge Jo-Kamimoto, MD; Andrew J Johnsrud, MD; Atul Kothari, MD; Mary J Burgess, MD; Carolina Schinke, MD; Sharmilan Thanendrarajan, MD, PhD; Maurizio Zangari, MD; Faith Davies, MBBCh, MRCP, MD, FRCPath; Gareth Morgan, Ph.D; Frits Vanrhee, MD, PhD; Juan Carlos Rico Crescencio, MD
  • IDSA_Johnsrud Dara poster.pdf (675.3 kB)
  •   Infectious Risks and Complications in Adult Acute Lymphoblastic Leukemia (ALL) Patients Receiving Blinatumomab
    Wonhee So, PharmD; Shuchi Pandya, MD; Rod Quilitz, PharmD, BCOP; John Greene, MD, FACP, FSHEA
    Classification of Death Causes after Transplantation (CLASS): Evaluation of Methodology and Initial Results.
    Neval Ete Wareham, MD; Caspar Da Cunha-Bang, MD; Álvaro H Borges, MD, PhD, MSc; Christina Ekenberg, MD; Jan Gerstoft, MD, DMSc, professor; Finn Gustafsson, MD; Ditte Hansen, MD, PhD; Marie Helleberg, MD, PhD, DMSc; Carsten Heilmann, MD, DMSc, Professor; Jens Hillingsø, MD; Paul Suno Krohn, MD; Isabelle Paula Lodding, MD; Thomas Kromann Lund, MD, PhD; Louise Lundgren, MD; Amanda Mocroft, MSc, Professor; Michael Perch, MD; Søren Lykke Petersen, MD, PhD; Irma Petruskevicius, MD; Allan Rasmussen, MD; Kasper Rossing, MD, PhD; Andreas Rostved, MD; Henrik Sengeløv, MD; Vibeke Rømming Sørensen, MD, PhD; Søren Schwartz Sørensen, MD; Jens Lundgren, MD, DMSc, Professor
  • Poster_IDWeek_NEEoct17.pdf (234.6 kB)
  • Incidence and risk factors for infections after liver transplant in children: single-center experience for 15 years
    Jae Choon Kim, MD; Joon Kee Lee, MD; Song I Yang, MD; Sun Hyoung Park, MD; Ki Wook Yoon, MD, PhD; Hyunju Lee, MD, PhD; Nam Joon Yi, MD. PhD.; Kyung Suk Suh, MD. PhD.; Eun Hwa Choi, MD, PhD; Hoan Jong Lee, MD, PhD
  • 2017 IDweek_LT_JCK.pdf (347.7 kB)
  • Febrile neutropenia as a marker of an infectious phenotype and poor long-term outcomes among patients treated with chemotherapy for malignant diseases
    Josefine Nordvig, Medical student; Theis Aagaard, MD; Gedske Daugaard, MD, DMSc, Professor; Peter Brown, MD, PhD; Henrik Sengeløv, MD; Jens Lundgren, MD, DMSc, Professor; Marie Helleberg, MD, PhD, DMSc
    Characteristics and Early Outcomes of Older Adults Undergoing Kidney Transplantation
    Marion Hemmersbach Miller, MD PhD; Kenneth Schmader, MD
  • Poster_004.pdf (183.4 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.